Reports
Reports
The global lung stent market size attained a value of about USD 97.47 million in 2022. The market is expected to grow at a CAGR of 6% during the forecast period of 2023-2031 to attain a value of early USD 164.68 million by 2031. The anticipated market growth can be attributed to the rising prevalence of respiratory disorders such as lung cancer, COPD, and asthma.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The global lung stent industry is being driven by the growing incidences of lung cancer and respiratory problems, the development of biodegradable stent, and the increased demand for customised lung stents.
A stent is a hollow pipe which can be inserted in the airway to widen the narrow area and help you breathe.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The global lung stent industry can be broadly categorised based on segments like types, materials, products, end-uses, and regions.
The EMR report looks into the regional lung stent markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The increasing prevalence of lung cancer and chronic respiratory disorders globally, coupled with the growing preference for minimally invasive procedures, are some of the factors contributing to the growth of the global lung stent industry. The growing preference for customised lung stent is further aiding the industry growth. However, the risk associated with the use of these stents, coupled with the increasing availability of alternative therapies, can hamper the industry growth over the forecast period. Region-wise, North America accounted for the largest share of this market in 2020 owing to the presence of advanced technology and large hospitals, and robust healthcare infrastructure.
The report presents a detailed analysis of the following key players in the global lung stent market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The EMR report gives an in-depth insight into the lung stent market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
REPORT FEATURES | DETAILS |
---|---|
Base Year | 2022 |
Historical Period | 2018-2022 |
Forecast Period | 2023-2031 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Type |
|
Breakup by Material |
|
Breakup by Product |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Lung Stent Market Overview
3.1 Global Lung Stent Market Historical Value (2016-2022)
3.2 Global Lung Stent Market Forecast Value (2023-2031)
4 Global Lung Stent Market Landscape
4.1 Global Lung Stent Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Lung Stent Product Landscape
4.2.1 Analysis by Type of Biosensor
4.2.2 Analysis by Technology Used
4.2.3 Analysis by Applications
5 Global Lung Stent Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Lung Stent Market Segmentation
6.1 Global Lung Stent Market by Type
6.1.1 Market Overview
6.1.2 Tracheobronchial Stents
6.1.3 Laryngeal Stents
6.2 Global Lung Stent Market by Material
6.2.1 Market Overview
6.2.2 Metal Stents
6.2.2.1 Nitinol Stents
6.2.2.2 Stainless Steel Stains
6.2.2.3 Others
6.2.3 Silicone Stents
6.2.4 Hybrid Stents
6.3 Global Lung Stent Market by Product
6.3.1 Market Overview
6.3.2 Self-Expandable Stents
6.3.3 Non-Expandable Stents
6.4 Global Lung Stent Market by End User
6.4.1 Market Overview
6.4.2 Hospitals
6.4.3 Ambulatory Surgery Centres
6.4.4 Others
6.5 Global Lung Stent Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Lung Stent Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Lung Stent Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Lung Stent Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Lung Stent Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Lung Stent Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Boston Scientific Corporation
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Taewoong Medical Co., Ltd.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Micro-Tech (Nanjing) Co., Ltd.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Bess Medizintechnik Gmbh
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 E. Benson Hood Laboratories, Inc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Merit Medical Systems, Inc.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Cook Group Incorporated
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Boston Medical Products, Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Novatech SA
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Standard Sci. Tech Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Stening SRL
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 ENDO-FLEX GmbH
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Micro-Tech
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
18 Global Lung Stent Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
In 2022, the global lung stent market attained a value of nearly USD 97.4 million.
The market is projected to grow at a CAGR of 6% between 2023 and 2031.
The major drivers of the market include the growing incidences of lung cancer and respiratory problems, the development of biodegradable stent, and the increased demand for customised lung stents.
The increasing prevalence of lung cancer and chronic respiratory disorders globally is a major industry trend aiding the market growth.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
Tracheobronchial stents and laryngeal stents are the leading types in the industry.
The leading materials in the market are metal stents, silicone stents, and hybrid stents.
Self-expandable and non-expandable stents are the leading products in the industry.
Hospitals and ambulatory surgery centres are the end-use sectors for the industry.
The major players in the industry are Boston Scientific Corporation, Taewoong Medical Co., Ltd., Micro-Tech (Nanjing) Co., Ltd., Bess Medizintechnik Gmbh, E. Benson Hood Laboratories, Inc., Merit Medical Systems, Inc., and Cook Group Incorporated, among others.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.